Spatial Genomics and Transcriptomic Market Overview 2030:
The global spatial genomics and transcriptomics market size was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million by 2030, registering a CAGR of 13.6% from 2021 to 2030.
The genomics provides an overview of the complete set of genetic commands provided by the DNA, while transcriptomics looks into gene appearance patterns. The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. Spatial genomics has a lot of potential in disease control, as it provides quantitative gene expression data as well as DNA and RNA visualization mapping into tissue components.
Increase in adoption of spatial genomics and transcriptomics technologies owing to their various applications such as stem cell and cancer research, tissue-specific gene expression studies, embryogenesis and in-vitro fertilization, and characterization of non-coding RNAs among others, drives the growth of the spatial genomics and transcriptomics market. In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers as well as growth in preference toward personalized medicines further fuel the growth of the market. However, dearth of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomic technologies are expected to hinder growth of the market during the forecast period. On the other hand, surge in innovations in spatial genomics and transcriptomic technologies is expected to offer profitable opportunities for the growth of the market during the forecast period.
Impact Of Covid-19 On Spatial Genomics and Transcriptomics Market (Pre And Post Analysis)
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global spatial genomics and transcriptomics market also declined in 2020, due to global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries such as academic & research, and pharmaceutical & biotechnological among others.
The impact of the pandemic and slowing global research activities have also had a negative impact on the operations and financial performance of many players in the market. Due to shutting down of academic & research institutes, there has been a decline in the sales of consumables & reagents used for spatial genomics & transcriptomics analysis. However, market witness recovery in the year 2021, owing to increase in adoption of spatial genomics & transcriptomics to profile COVID-19 tissue autopsies as well as rise in biomarker identification and its use in drug discovery and development programs.
Spatial Genomics And Transcriptomic Market Segmentation
The global spatial genomics and transcriptomic market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is again segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction. In addition, the spatial genomics analysis segment is further segmented into fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into, pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
By technique, the market is segmented into spatial transcriptomics, and spatial genomics analysis. The spatial genomics analysis segment dominated the global market in 2020, and is expected to remain dominant throughout the forecast period, owing to emerging potential of spatial genomic analysis as a cancer diagnostic tool.
By product type, the spatial genomics and transcriptomics market is segregated into instruments, consumables, and software. The consumables segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to rise in demand for consumables, which are required to run the instruments across various stages of genome mapping from sample preparation to result derivation.
By Technique
Spatial Genomics Analysis segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
By application, the market is classified into translational research, and drug discovery & development. The drug discovery & development held the largest spatial genomics and transcriptomics market share in 2020, and is expected to remain dominant throughout the forecast period, owing to growth in application of spatial genomic and transcriptomics technologies in drug discovery & development.
By end user, the market is classified into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. The academic & research institutes dominated the global market in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in genomic research projects conducted by academic research institutes as well as collaboration among major players and universities for development of novel approaches to curing chronic conditions through genetic medicine.
By Product Type
Consumables segment is projected as one of the most lucrative segment.
Snapshot of the Europe Spatial Genomics and Transcriptomic Market
The Europe market is expected to harbor high growth potential with the ongoing developments in the spatial genomics and transcriptomics technologies and many renowned players have adopted key strategies such as product launch and acquisition, to increase their market share. R&D and technological innovation of the spatial genomics and transcriptomics technologies, have further increased the importance of spatial genomics and transcriptomics technologies in the pharmaceutical and biotechnology industry in Europe. Moreover, Germany, France, and the UK are expected to grow at high CAGR in the Europe spatial genomics and transcriptomics market, owing to factors such as developed healthcare and increase in adoption of spatial genomics and transcriptomics technologies. The UK is a leading country after the U.S. in terms of investment and number of spatial genomics and transcriptomics technology companies.
The key spatial genomics and transcriptomic market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc.), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.
By Region
North America is expected to experience growth at the highest rate, registering a CAGR of 10.6 % during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the global spatial genomics and transcriptomic market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the spatial genomics and transcriptomics market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing spatial genomics and transcriptomics market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of spatial genomics and transcriptomics used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the spatial genomics and transcriptomics market.
Spatial Genomics and Transcriptomics Market Report Highlights
| Aspects | Details |
 By Technique |
|
 By Product Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 By Key Market Players |
|
Analyst Review
The global spatial genomics and transcriptomic market is expected to exhibit high growth potential attributed to increase in adoption of spatial genomics and transcriptomics technologies owing to its various applications, growth in prevalence of genetic disorders, and rise in preference toward personalized medicines.
North America is expected to witness the highest growth in terms of revenue, owing to increase in awareness related to genetic disorders among patients, high per capita healthcare expenditure and high prevalence of target diseases. In addition, presence of majority of key players in this region is a key factor for the growth of the spatial genomics and transcriptomic market.
Europe was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to upsurge in the technological investments and the growing awareness, and development employing the use of spatial genomics and transcriptomic technologies in the region. However, Asia-Pacific is expected to emerge as a lucrative market with maximum growth potential, owing to increase in number of initiatives and enhanced investments for the overall R&D of spatial genomics and transcriptomics technologies. In addition, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high growth opportunities boost the market.
The total market value of spatial genomics and transcriptomic market is $626.9 million in 2020.
The forcast period for spatial genomics and transcriptomic market is 2021 to 2030
The market value of spatial genomics and transcriptomic market in 2021 is $683.95 million.
The base year is 2020 in spatial genomics and transcriptomic market
Top companies such as Illumina Inc, 10X Genomics, Inc., Nanostring Technologies, Bio-Techne Group, Tecan Group, and Natera Inc. held a high market position in 2020.
The spatial genomics analysis segment is the most influencing segment owing to emerging potential of spatial genomic analysis as cancer diagnostic tool, and advent of the fourth generation of sequencing
increase in adoption of spatial genomics and transcriptomics technologies owing to its various application, growth in prevalence of genetic disorders, and rise in preference toward personalized medicines are some factors, which is expected to propel growth of the spatial genomics and transcriptomic market during the forecast period.
Asia-Pacific is expected to experience the growth rate of 14.9% during the forecast period, owing to increase in number of initiatives and enhanced investments for the overall R&D of spatial genomics and transcriptomics technologies in the region.
The Genomics provides an overview of the complete set of genetic commands provided by the DNA, while transcriptomics looks into gene appearance patterns. The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics.
Spatial genomics & transcriptomic is a new discipline involving the identification of high-performance information concerning the organizational composition of tissue and cell content
Loading Table Of Content...
